Biased Evaluation in Cancer Drug Trials-How Use of Progression-Free Survival as the Primary End Point Can Mislead
- PMID: 35266952
- DOI: 10.1001/jamaoncol.2021.8206
Biased Evaluation in Cancer Drug Trials-How Use of Progression-Free Survival as the Primary End Point Can Mislead
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
